ONEMEDNET CORP (ONMD) Fundamental Analysis & Valuation

NASDAQ:ONMD • US68270C1036

Current stock price

0.7953 USD
-0.02 (-2.89%)
At close:
0.7672 USD
-0.03 (-3.53%)
Pre-Market:

This ONMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ONMD Profitability Analysis

1.1 Basic Checks

  • ONMD had negative earnings in the past year.
  • In the past year ONMD has reported a negative cash flow from operations.
  • ONMD had negative earnings in each of the past 5 years.
  • ONMD had negative operating cash flow in 4 of the past 5 years.
ONMD Yearly Net Income VS EBIT VS OCF VS FCFONMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

  • ONMD's Return On Assets of -150.07% is on the low side compared to the rest of the industry. ONMD is outperformed by 91.43% of its industry peers.
Industry RankSector Rank
ROA -150.07%
ROE N/A
ROIC N/A
ROA(3y)-1920.19%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONMD Yearly ROA, ROE, ROICONMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ONMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONMD Yearly Profit, Operating, Gross MarginsONMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ONMD Health Analysis

2.1 Basic Checks

  • ONMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ONMD has been increased compared to 1 year ago.
  • The debt/assets ratio for ONMD has been reduced compared to a year ago.
ONMD Yearly Shares OutstandingONMD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
ONMD Yearly Total Debt VS Total AssetsONMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • ONMD has an Altman-Z score of -112.27. This is a bad value and indicates that ONMD is not financially healthy and even has some risk of bankruptcy.
  • ONMD has a Altman-Z score of -112.27. This is amonst the worse of the industry: ONMD underperforms 97.14% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -112.27
ROIC/WACCN/A
WACC8.55%
ONMD Yearly LT Debt VS Equity VS FCFONMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

  • ONMD has a Current Ratio of 0.29. This is a bad value and indicates that ONMD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ONMD has a Current ratio of 0.29. This is amonst the worse of the industry: ONMD underperforms 91.43% of its industry peers.
  • ONMD has a Quick Ratio of 0.29. This is a bad value and indicates that ONMD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.29, ONMD is not doing good in the industry: 91.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
ONMD Yearly Current Assets VS Current LiabilitesONMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ONMD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 93.45% over the past year.
  • The Revenue for ONMD has decreased by -69.79% in the past year. This is quite bad
  • The Revenue for ONMD have been decreasing by -16.18% on average. This is quite bad
EPS 1Y (TTM)93.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.89%
Revenue 1Y (TTM)-69.79%
Revenue growth 3Y-16.18%
Revenue growth 5YN/A
Sales Q2Q%24.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ONMD Yearly Revenue VS EstimatesONMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ONMD Valuation Analysis

4.1 Price/Earnings Ratio

  • ONMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONMD Price Earnings VS Forward Price EarningsONMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONMD Per share dataONMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ONMD Dividend Analysis

5.1 Amount

  • ONMD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ONMD Fundamentals: All Metrics, Ratios and Statistics

ONEMEDNET CORP

NASDAQ:ONMD (3/19/2026, 8:21:55 PM)

Premarket: 0.7672 -0.03 (-3.53%)

0.7953

-0.02 (-2.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners11.67%
Inst Owner Change-50.94%
Ins Owners58.25%
Ins Owner Change7.18%
Market Cap40.57M
Revenue(TTM)495.00K
Net Income(TTM)-2.26M
AnalystsN/A
Price TargetN/A
Short Float %2.14%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 81.96
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.01
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -150.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1920.19%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3101.22%
Cap/Sales 513.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -112.27
F-Score3
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)1855.97%
Cap/Depr(5y)N/A
Cap/Sales(3y)156.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-69.79%
Revenue growth 3Y-16.18%
Revenue growth 5YN/A
Sales Q2Q%24.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-112.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.18%
OCF growth 3YN/A
OCF growth 5YN/A

ONEMEDNET CORP / ONMD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ONEMEDNET CORP (ONMD) stock?

ChartMill assigns a fundamental rating of 0 / 10 to ONMD.


What is the valuation status of ONEMEDNET CORP (ONMD) stock?

ChartMill assigns a valuation rating of 0 / 10 to ONEMEDNET CORP (ONMD). This can be considered as Overvalued.


What is the profitability of ONMD stock?

ONEMEDNET CORP (ONMD) has a profitability rating of 0 / 10.